Concentrum Wealth Management

Position in MRK — Merck & Co., Inc.

CIK 1765387 SAN JOSE, CA

Position in MRK

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$506,161

+$39,436 QoQ

Shares Held

3,939

+1.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#2,686

of 3,769 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Concentrum Wealth Management holds $3,763,659 across 6 Drug Manufacturers - General names. MRK ranks #5 (13.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	3,991	$1,013,594
2	AMGN	Amgen Inc	1,954	$707,582
3	GILD	Gilead Sciences, Inc.	5,333	$673,771
4	ABBV	AbbVie Inc.	2,422	$609,472
5	MRK	Merck & Co., Inc. This page	3,939	$506,161
6	LLY	ELI LILLY & Co	211	$253,079

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$506,161	3,939	+1.5%	Shares	Sole	2026-08-06
2026-03-31	$466,725	3,880	—	Shares	Sole	2026-05-04
No filing history on record for this holder in this stock.